Anti-CD300a/d (MAIR-I/II) (Mouse) mAb-FITC
Code | Size | Price |
---|
MBL-D178-4 | 100 ul | £328.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rat
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: TX10
Regulatory Status: RUO
Target Species: Mouse
Application: Flow Cytometry
Shipping:
4°C
Storage:
4°C
Images
Documents
Further Information
Applications:
FCM - 10 ug/mL (final concentration)
Background:
Immune responses are regulated by
opposing positive and negative signals triggered by the
interaction of activating and inhibitory cell surface
receptors with their ligands. Shibuya et al. identified novel
paired activated and inhibitory immunoglobulin-like
receptors, designated myeloid-associated
immunoglobulin-like receptor (MAIR) I and MAIR-II,
whose extracellular domains are highly conserved by each
other. MAIR-I, expressed on the majority of myeloid cells,
including macrophages, granulocytes, mast cells, and
dendritic cells, contains the tyrosine-based sorting motif
and the immunoreceptor tyrosine-based inhibitory
motif-like sequences in the cytoplasmic domains. On the
other hand, MAIR-II, expressed on subsets of peritoneal
macrophages and B cells, associates with the
immunoreceptor tyrosine-based activation motif-bearing
adaptor DAP12. MAIR-I is also known as CD300a/
CMRF-35-like Ig-like molecule-8 (CLM-8)/leukocyte
mono-Ig-like receptor 1 (LMIR1). MAIR-II is also known
as CD300d/LMIR2/CLM-4/dendritic cell-derived Ig-like
receptor 1 (DIgR1).
Concentration:
500 ug/ml
Conjugate:
FITC
Formulation:
50 ug IgG in 100 ul volume of PBS containing 1% BSA and 0.09% NaN3.*Azide may react with copper or lead in plumbing system to form explosive metal azides. Therefore, always flush plenty ofwater when disposing materials containing azide into drain.
Gene IDs:
Human: 11314 Mouse: 217303
Immunogen Translated:
Ba/F3 cells were transfected with mouse MAIR-I
Reactivity:
This antibody reacts with mouse
CD300a/d antigen on Flow cytometry.
Shelf Life:
1 year
Source:
This antibody was purified from hybridoma
(clone TX10) supernatant using protein G agarose. This
hybridoma was established by fusion of mouse myeloma
cell Sp2/0 with Wister rat lymphocyte immunized with the
mouse MAIR-II transfected Ba/F3 cells.
Target:
MAIR-1/2
References
1) Nakahashi, C., et al., J. Immunol. 178, 765-770 (2007)
2) Okoshi, Y., et al., Int. Immunol. 17, 65-72 (2005)
3) Yotsumoto, K., et al., J. Exp. Med. 198, 223-233 (2003)
Clone TX10 is used in reference number 2) and 3).